Heart disease, stroke less widespread among foreign-born vs. US-born adults
DALLAS, March 28, 2018 — Foreign-born adults living in the United States had a lower prevalence of coronary heart disease and stroke than U.S.-born adults in nationally representative data spanning 2006-2014, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Researchers from the Centers for Disease Control and Prevention compared the prevalence of coronary heart disease and stroke among U.S. adults by birthplace. The proportion of adults living in the United States who were born elsewhere has almost tripled from about 9.6 million in 1970 to 40 million in 2010.
After adjusting for age and select demographic and health characteristics, researchers found that overall:
- The percentage of U.S. men who report having coronary heart disease was 8.2 percent among those born in the United State versus 5.5 percent for those born in another country.For women with coronary heart disease, the figures were 4.8 percent for those born in the United States and 4.1 percent for those born elsewhere.
- The percentage of the population living with stroke was 2.7 percent for U.S.-born men and women compared to 2.1 percent for foreign-born men and 1.9 percent for foreign-born women.
- The number of years people had been living in the United States was not related to risk of coronary heart disease or stroke after adjustment with demographic and health characteristics.
Comparing individual regions with those of U.S.-born, coronary heart disease prevalence was lower among people born in Asia, Mexico, Central America or the Caribbean. Stroke prevalence was lowest among men born in South America or Africa and women from Europe.
The reason foreign-born adults fare better could be explained by the "healthy immigrant effect", where those who decide to immigrate to another country are usually healthier than others, due to either self-selection or physical/legal barriers.
Researchers said these findings may support efforts to target high-risk groups with public health interventions.
The study was led by Jing Fang, M.D., M.S., of the Centers for Disease Control and Prevention. The author reported no conflicts of interest.
A commentary by Eduardo Sanchez, M.D., M.P.H., American Heart Association Chief Medical Officer for Prevention and Chief of the Centers for Health Metrics and Evaluation, will be available on this manuscript.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at http://www.heart.org/corporatefunding.
About the American Heart Association
The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation's oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.
Related Journal Article